Very interesting interview on a number of levels.
TODOS
Looking to go from being a distributor only to the Manufacturing arm in the US for the covid tests.
As far as LymPro moving into a CLIA Lab, Gerald talks about moving it into a Lab they are in the process of purchasing/acquiring.
The only CLIA Lab that has been mentioned that they (TODOS) is in the process of acquiring at this point is Provista Diagnostics which will include their CLIA Lab in Georgia.
AMBS also owns about 30% in AVDX which has a lab, but that is not CLIA certified, yet.
To be able to validate LymPro essentially for free and then run testing all in house will be one, an inexpensive fast track to market and then two, a steady revenue stream once companies begin using LymPro. Dual revenue streams.
1. For LymPro
2. For running the study samples through the CLIA lab.
The last really interesting part of this whole interview is that is was Sponsored by none other than
INVESTORS HANGOUT.
the program is the Stock Day Podcast hosted by Everett Jolly.
I personally have never heard of him or his show, but I haven't hear of a lot of people to be 100 percent fair.
I haven't seen him post here or on the TODOS board.
Anyone know of him here?
I am not promoting him or his show; I have never heard of either since just now.
stockdaymedia.com/todos-medicals-gerald-commissiong-joins-everett-jolly-on-the-stock-day-podcast-tomdf-april-28-2020/
TODOS
Looking to go from being a distributor only to the Manufacturing arm in the US for the covid tests.
As far as LymPro moving into a CLIA Lab, Gerald talks about moving it into a Lab they are in the process of purchasing/acquiring.
The only CLIA Lab that has been mentioned that they (TODOS) is in the process of acquiring at this point is Provista Diagnostics which will include their CLIA Lab in Georgia.
AMBS also owns about 30% in AVDX which has a lab, but that is not CLIA certified, yet.
To be able to validate LymPro essentially for free and then run testing all in house will be one, an inexpensive fast track to market and then two, a steady revenue stream once companies begin using LymPro. Dual revenue streams.
1. For LymPro
2. For running the study samples through the CLIA lab.
The last really interesting part of this whole interview is that is was Sponsored by none other than
INVESTORS HANGOUT.
the program is the Stock Day Podcast hosted by Everett Jolly.
I personally have never heard of him or his show, but I haven't hear of a lot of people to be 100 percent fair.
I haven't seen him post here or on the TODOS board.
Anyone know of him here?
I am not promoting him or his show; I have never heard of either since just now.
stockdaymedia.com/todos-medicals-gerald-commissiong-joins-everett-jolly-on-the-stock-day-podcast-tomdf-april-28-2020/
